This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, G. Articles by Krishan, A. Search for Related Content PubMed PubMed Citation Articles by Chen, G. Articles by Krishan, A.

Thaliblastine, a Plant Alkaloid, Circumvents Multidrug Resistance by Direct Binding to P-Glycoprotein¹

Division of Experimental Therapeutics, Department of Radiation Oncology, University of Miami Medical School, Miami, Florida 33136

The effect of thaliblastine (TBL, NSC-68075), a plant alkaloid, in over-coming multidrug resistance was investigated in doxorubicin (ADR)-resistant murine leukemic P388/R-84 cells. In the soft agar clonogenic assay, a nontoxic concentration of TBL (2 µM) reduced the 50% inhibitory dose of ADR (1-h exposure) from 10.8 to 1.4 µM with a dose modification factor of 7.7. Continuous treatment of P388/R-84 cells with ADR and TBL for 24 h further lowered the 50% inhibitory dose from 3.5 to 0.07 µM, the resistance level being decreased from 233-fold in the absence of TBL to 4.7-fold in the presence of TBL as compared to the parental P388 cells. Although ADR or TBL individually had no detectable effects on cell cycle traverse, the combination of the two drugs caused a significant G₂ block. Flow cytometric analysis showed that TBL enhanced ADR retention in P388/R-84 cells in a dose- and time-dependent manner. TBL partially blocked the photolabeling of P-glycoprotein with [³H]azidopine, and this blocking effect was further enhanced in combination with ADR. Our results indicate that TBL can reverse multidrug resistance by direct interaction with P-glycoprotein, thereby increasing cellular ADR retention.

¹ This work was supported by NIH Grant CA-29360.

² Present address: Dana-Farber Cancer Institute, JF-525, 44 Binney Street, Boston, MA 02115.

³ To whom requests for reprints should be addressed, at Division of Experimental Therapeutics, Department of Radiation Oncology, University of Miami School of Medicine, P. O. Box 016960 (R-71), Miami, FL 33101.

Received 11/16/92. Accepted 3/24/93.

This article has been cited by other articles:

				K. P. Gupta, N. E. Ward, K. R. Gravitt, P. J. Bergman, and C. A. O'Brian Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C-alpha Pseudosubstrate Peptide J. Biol. Chem., January 26, 1996; 271(4): 2102 - 2111. [Abstract] [Full Text] [PDF]